01967nam a2200457 i 4500001001300000003000600013005001700019007001400036008004100050040003000091042000800121043001200129074001600141086002000157110007300177245015700250264007100407300002300478336000800501337001600509338001900525490007700544500002400621500002100645500003600666500002500702504004100727533010600768776013100874776013201005810005801137050002101195610004101216610007001257650003901327650003601366650004501402650001401447650001401461655003401475on1062364004OCoLC20181218152603.0he bmb024bbca181109s2018    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---  a1008-D (MF)0 aY 1.1/8:115-7251 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce,10aMedicaid Partnership Act :breport together with additional views (to accompany H.R. 5801) (including cost estimate of the Congressional Budget Office). 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2018]  a37 pages ;c24 cm.  btxt  bh2rdamedia  bhe2rdacarrier1 aReport / 115th Congress, 2d session, House of Representatives ;v115-725  aTitle from caption.  a"June 12, 2018."  aShipping list no.: 2018-0192-M.  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce.tMedicaid Partnership Actw(OCoLC)104208604808iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce.tMedicaid Partnership Actw(OCoLC)10420750931 aUnited States.bCongress.bHouse.tReport ;v115-725. 4aKF32b.E55 2018w10aUnited States.tSocial Security Act.10aUnited States.bFood and Drug AdministrationxRules and practice. 0aDrugsxPrescribingzUnited States. 0aDrug monitoringzUnited States. 0aOpioid abusezUnited StatesxPrevention. 0aMedicaid. 0aMedicare. 7aLegislative materials.2lcgft